1,491
Views
1
CrossRef citations to date
0
Altmetric
HPV

HPV vaccine knowledge, attitudes, and practices among New York State medical providers, dentists, and pharmacists

, , &
Article: 2219185 | Received 17 Feb 2023, Accepted 22 May 2023, Published online: 21 Jun 2023

References

  • CDC. Cancers associated with human papillomavirus, United States – 2015-2019. In: USCS data brief, no. 32. Atlanta (GA): Centers for Disease Control and Prevention, US Department of Health and Human Services; 2022.
  • Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the advisory committee on immunization practices. MMWR. 2016;65(49):1405–11. doi:10.15585/mmwr.mm6549a5.
  • Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Wiliams CL, Fredua B, McNamara LA, Stokley S, Singleton JA. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2020. MMWR. 2021;70(35):1183–90. doi:10.15585/mmwr.mm7035a1.
  • CDC. TeenVaxView. [accessed 2023 Jan 12]. https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/index.html.
  • Dorell C, Yankey D, Kennedy A, Stokely S. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey – Teen, 2010. Clin Pediatr. 2013;52(2):162–70. doi:10.1177/0009922812468208.
  • Reiter PL, McRee AL, Pepper JK, Gilkey MB, Galbraith KV, Brewer NT. Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health. 2013;103(8):1419–27. doi:10.2105/AJPH.2012.301189.
  • Lau M, Lin H, Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 national survey of children’s health. Vaccine. 2012;30(20):3112–8. doi:10.1016/j.vaccine.2012.02.034.
  • Caldwell AC, Madden CA, Thompson DM, Garbe MC, Roberts JR, Jacobson RM, Darden PM. The impact of provider recommendation on human papillomavirus vaccine and other adolescent vaccines. Hum Vaccin Immunother. 2021;17(4):1059–67. doi:10.1080/21645515.2020.1817713.
  • Lin C, Mullen J, Smith D, Kotarba M, Kaplan SJ, Tu P. Healthcare providers’ vaccine perceptions, hesitancy, and recommendation to patients: a systematic review. Vaccines. 2021;9(7):713. doi:https://doi.org/10.3390/vaccines9070713.
  • Rosen BL, Shepard A, Kahn JA. US health care clinicians’ knowledge, attitudes, and practices regarding human papillomavirus vaccination: a qualitative systematic review. Acad Pediatr. 2018;18(2):S53–S65. doi:10.1016/j.acap.2017.10.007.
  • Oh NL, Biddell CB, Rhodes BE, Brewer NT. Provider communication and HPV vaccine uptake: a meta-analysis and systematic review. Prev Med. 2021;148:106554. doi:10.1016/j.ypmed.2021.106554.
  • Yared N, Malone M, Welo E, Mohammed I, Groene E, Flory M, Basta NE, Horvath KJ, Kulasingam S. Challenges related to human papillomavirus (HPV) vaccine uptake in minnesota: clinician and stakeholder perspectives. Cancer Cause Control. 2021;32(10):1107–16. doi:10.1007/s10552-021-01459-5.
  • Gilkey MB, McRee AL. Provider communication about HPV vaccination: a systematic review. Human Vaccin Immunother. 2016;12(6):1454–68. doi:10.1080/21645515.2015.1129090.
  • Richman AR, Torres E, Wu Q, Eldridge D, Lawson L. HPV vaccine recommendation practices of current and future physicians in North Carolina: an exploratory study. Health Educ Res. 2022;37(4):213–26. doi:10.1093/her/cyac016.
  • Casey SM, Paiva T, Perkins RB, Villa, Murray EJ. Could oral health care professionals help increase human papillomavirus vaccination rates by engaging patients in discussion? JADA. 2023;154(1):10–23. doi:10.1016/j.adaj.2022.09.014.
  • Btoush R, Kohler RK, Carmody DP, Hudson SV, Tsui J. Factors that influence the healthcare provider recommendation of HPV vaccination. Quant Res. 2022;36(7):1152–61. doi:10.1177/08901171221091438.
  • Suryadevara M, Handel A, Bonville CA, Cibula DA, Domachowske JB. Pediatric provider vaccine hesitancy: an under-recognized obstacle to immunizing children. Vaccine. 2015;33(48):6629–34. doi:10.1016/j.vaccine.2015.10.096.
  • Suryadevara M, Bonville CA, Cibula DA, Domachowske JB. Cancer prevention education for providers, staff, parents, and teens improves adolescent human papillomavirus immunization rates. J Pediatr. 2019;205:145–52. doi:10.1016/j.jpeds.2018.09.013.
  • American Dental Association. ADA policy on HPV vaccination. [accessed 2023 Jan 5]. https://www.ada.org/resources/research/science-and-research-institute/oral-health-topics/cancer-head-and-neck.
  • Food and Drug Administration. Gardasil 9. [accessed 2023 Jan 12]. https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9.
  • Hess K, Bach A, Won K, Seed SM. Community pharmacists roles during the COVID-19 pandemic. J Pharm Pract. 2020;15(3):469–76. doi:10.1177/0897190020980626.
  • Tolentino V, Unni E, Montuoro J, Bezzant-Ogborn D, Kepka D. Utah pharmacists’ knowledge, attitudes, and barriers regarding human papillomavirus vaccine recommendation. J Am Pharm Assoc. 2018;58(4):S16–s23. doi:10.1016/j.japh.2018.04.014.
  • Di Castri AM, Halperin DM, Ye L, MacKinnon-Cameron D, Kervin M, Isenor JE, Halperin SA. Healthcare provider awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizers. Hum Vaccin Immunother. 2022;18(7):2147356. doi:10.1080/21645515.2022.2147356.
  • Stull CL, Lunos S. Knowledge, attitudes and practices regarding human papilloma virus communication and vaccine advocacy among minnesota dentists and dental hygienists. J Dent Hyg. 2019;93:33–42.
  • Canon C, Effoe V, Shetty V, Shetty AK. Knowledge and attitudes towards human papillomavirus (HPV) among academic and community physicians in Mangalore< india. J Cancer Educ. 2017;32(2):382–91. doi:10.1007/s13187-016-0999-0.
  • Koskan A, Vizcaino M, Brennhofer SA, Lee CD, Robert AJ. Human papillomavirus vaccine administration behaviors and influences among Arizona pharmacists and pharmacy interns. Hum Vaccin Immunother. 2021;17(9):3090–5. doi:10.1080/21645515.2021.1905469.
  • Wright M, Pazdernik V, Luebbering C, Davis JM. Dental students’ knowledge and attitudes about human papillomavirus prevention. Vaccines (Basel). 2021;9(8):888. doi:10.3390/vaccines9080888.
  • Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. doi:10.1016/j.jbi.2008.08.010.
  • Harris PA, Taylor R, Minor BL, Elliott V, Fernandez, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, et al. The REDCap consortium: building an international community of software partners. J Biomed Inform. 2019;9:103208. doi:10.1016/j.jbi.2019.103208.
  • Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent young women. Am J Prev Med. 2012;42(1):44–52. doi:10.1016/j.amepre.2011.09.024.
  • Bonville CA, Domachowske JB, Cibula DA, Suryadevara M. Immunization attitudes and practices among family medicine providers. Hum Vaccin Immunother. 2017;13(11):2646–53. doi:10.1080/21645515.2017.1371380.
  • Kempe A, O’Leary ST, Markowitz LE, Crane LA, Hurley LP, Brtnikova M, Beaty BL, Meites E, Stokley S, Lindley MC. HPV vaccine delivery practices by primary care physicians. Pediatrics. 2019;144(4):e20191475. doi:10.1542/peds.2019-1475.
  • Allison MA, Hurley LP, Markowitz L, Crane LA, Brtnikova M, Beaty BL, Snow M, Cory J, Stokley S, Roark J, et al. Primary care physicians’ perspectives about HPV vaccine. Pediatrics. 2016;137(2):e20152488. doi:10.1542/peds.2015-2488.
  • Hofstetter AM, Lappetito L, Stockwell MS, Rosenthal SL. Human papillomavirus vaccination of adolescents with chronic medical conditions: a national survey of pediatric subspecialists. J Pediatr Adolesc Gynecol. 2017;30(1):88–95. doi:10.1016/j.jpag.2016.08.005.
  • Romaire MA. Use of primary care and specialty providers: findings from the medical expenditure panel survey. J Gen Int Med. 2020;35(7):2003–9. doi:10.1007/s11606-020-05773-7.
  • Arnell TL, York C, Nadeau A, Donnelly, Till L, Zargari P, Davis W, Finley C, Delaney T, Carney J. The role of the dental community in oropharyngeal cancer prevention through HPV vaccine advocacy. J Cancer Educ. 2021;36(2):299–304. doi:10.1007/s13187-019-01628-w.
  • Berenson AB, Hirth JM, Southerland JH. Knowledge of human papillomavirus among dental providers: a mixed methods study. Vaccine. 2020;38(3):423–6. doi:10.1016/j.vaccine.2019.10.068.
  • Patel S, Koskan A, Spolarich A, Perry M, Flood T. Dental professionals’ knowledge, attitudes, and practice behaviors related to human papillomavirus vaccination. J Public Health Dent. 2020;80(1):61–9. doi:10.1111/jphd.12350.
  • Daley EM, Thompson EL, Beckstead J, Driscoll A, Vamos C, Piepenbringk RP, Desch J, Merrell L, Cayama MBR, Owens H, et al. Discussing HPV and oropharyngeal cancer in dental settings: gender and provider type matter. Hum Vaccin Immunother. 2021;17(12):5454–9. doi:10.1080/21645515.2021.1996809.
  • Stull C, Freese R, Sarvas E. Parent perceptions of dental providers’ role in HPV prevention and HPV vaccine advocacy. J Am Dent Assoc. 2020;151(8):560–7. doi:10.1016/j.adaj.2020.05.004.
  • Lazalde GE, Gilkey MB, Kornides ML, McRee AL. Parent perceptions of dentists’ role in HPV vaccination. Vaccine. 2018;36(4):461–6. doi:10.1016/j.vaccine.2017.12.020.
  • Harris KL, Tay D, Kaiser D, Praag A, Rutkoski H, Dixon BL, Pinzon LM, Winkler JR, Kepka D. The perspectives, barriers, and willingness of Utah dentists to engage in human papillomavirus (HPV) vaccine practices. Hum Vaccin Immunother. 2020;16(2):436–44. doi:10.1080/21645515.2019.1649550.
  • Walker KK, Jackson RD, Sommariva S, Neelamegam M, Desch J. USA dental health providers’ role in HPV vaccine communication and HPV-OPC protection: a systematic review. Human Vaccin Immunother. 2019;15(7–8):1863–9. doi:10.1080/21645515.2018.1558690.
  • Guadiana D, Kavanagh NM, Squarize CH. Oral health care professionals recommending and administering the HPV vaccine: understanding the strengths and assessing the barriers. PLoS One. 2021;16(3):e0248047. doi:10.1371/journal.pone.0248047.
  • Wick JA, Elswick BM. Impact of pharmacist delivered education on early parent awareness and perceptions regarding human papillomavirus (HPV) vaccination in the community pharmacy setting in West Virginia. Innov Pharm. 2018;9(3):1–6. doi:10.24926/iip.v9i3.1396.
  • Hastings TJ, Hohmann LA, McFarland SJ, Teeter BS, Westrick SC. Pharmacists’ attitudes and perceived barriers to human papillomavirus (HPV) vaccination services. Pharmacy (Basel). 2017;5(4):45. doi:10.3390/pharmacy5030045.
  • Ryan G, Daly E, Askelson N, Pieper F, Seegmiller L, Allred T. Exploring opportunities to leverage pharmacists in rural areas to promote administration of human papillomavirus vaccine. Prev Chronic Dis. 2020;17:E23. doi:10.5888/pcd17.190351.
  • Daniel CL, McLendon L, Green CL, Anderson KJ, Pierce JY, Perkins A, Beasley M. HPV and HPV vaccination knowledge and attitudes among medical students in Alabama. J Cancer Educ. 2021;36(1):168–77. doi:10.1007/s13187-019-01613-3.
  • Tolentino V, Unni E, Montuoro J, Bezzant-Ogborn D, Kepka D. Utah pharmacists’ knowledge, attitudes, and barriers regarding human papillomavirus vaccine recommendation. J Am Pharm Assoc. 2018;58(4):S16–S23. doi:10.1016/j.japh.2018.04.014.